The evaluation of overall hemostatic potential assay in patients with COVID-19 infection
Niki Lee
Northern Pathology Victoria, Northern Health, Epping, Victoria, Australia
Search for more papers by this authorJulie Wang
Northern Pathology Victoria, Northern Health, Epping, Victoria, Australia
Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia
Department of Medicine (Austin Health & Northern Health), University of Melbourne, Heidelberg, Victoria, Australia
Search for more papers by this authorRowena Brook
Northern Pathology Victoria, Northern Health, Epping, Victoria, Australia
Search for more papers by this authorPaul Monagle
Department of Paediatrics, Kids Cancer Centre, Sydney Children's Hospital, University of Melbourne, Heidelberg, Victoria, Australia
Department of Haematology, Royal Children's Hospital, Murdoch Children's Research Institute, Melbourne, Victoria, Australia
Search for more papers by this authorGeoffrey Donnan
The Melbourne Brain Centre, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia
Search for more papers by this authorHarshal Nandurkar
Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia
Search for more papers by this authorPrahlad Ho
Northern Pathology Victoria, Northern Health, Epping, Victoria, Australia
Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia
Department of Medicine (Austin Health & Northern Health), University of Melbourne, Heidelberg, Victoria, Australia
Search for more papers by this authorCorresponding Author
Hui Yin Lim
Northern Pathology Victoria, Northern Health, Epping, Victoria, Australia
Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia
Department of Medicine (Austin Health & Northern Health), University of Melbourne, Heidelberg, Victoria, Australia
Correspondence
Hui Yin Lim, Northern Pathology Victoria, Northern Health, 185 Cooper St., Epping, VIC 3076, Australia.
Email: [email protected]
Search for more papers by this authorNiki Lee
Northern Pathology Victoria, Northern Health, Epping, Victoria, Australia
Search for more papers by this authorJulie Wang
Northern Pathology Victoria, Northern Health, Epping, Victoria, Australia
Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia
Department of Medicine (Austin Health & Northern Health), University of Melbourne, Heidelberg, Victoria, Australia
Search for more papers by this authorRowena Brook
Northern Pathology Victoria, Northern Health, Epping, Victoria, Australia
Search for more papers by this authorPaul Monagle
Department of Paediatrics, Kids Cancer Centre, Sydney Children's Hospital, University of Melbourne, Heidelberg, Victoria, Australia
Department of Haematology, Royal Children's Hospital, Murdoch Children's Research Institute, Melbourne, Victoria, Australia
Search for more papers by this authorGeoffrey Donnan
The Melbourne Brain Centre, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia
Search for more papers by this authorHarshal Nandurkar
Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia
Search for more papers by this authorPrahlad Ho
Northern Pathology Victoria, Northern Health, Epping, Victoria, Australia
Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia
Department of Medicine (Austin Health & Northern Health), University of Melbourne, Heidelberg, Victoria, Australia
Search for more papers by this authorCorresponding Author
Hui Yin Lim
Northern Pathology Victoria, Northern Health, Epping, Victoria, Australia
Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia
Department of Medicine (Austin Health & Northern Health), University of Melbourne, Heidelberg, Victoria, Australia
Correspondence
Hui Yin Lim, Northern Pathology Victoria, Northern Health, 185 Cooper St., Epping, VIC 3076, Australia.
Email: [email protected]
Search for more papers by this authorFunding information: National Health and Medical Research Council, Grant/Award Number: APP1151535; Heart Foundation Health Professional Scholarship; Dr Lim is a recipient of the co-funded National Health and Medical Research Council (NHMRC) postgraduate scholarship and Heart Foundation Health Professional Scholarship. This funding, however, is independent of this research work.
Open Research
DATA AVAILABILITY STATEMENT
Authors elect to not share data.
REFERENCES
- 1Falasca L, Nardacci R, Colombo D, et al. Postmortem findings in Italian patients with COVID-19: a descriptive full autopsy study of cases with and without comorbidities. J Infect Dis. 2020; 222: 1807-1815. doi:10.1093/infdis/jiaa578
- 2Klok FA, Kruip M, van der Meer N, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191: 145-147. doi:10.1016/j.thromres.2020.04.013
- 3Zuo Y, Warnock M, Harbaugh A, et al. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients. Sci Rep. 2021; 11: 1580. doi:10.1038/s41598-020-80010-z
- 4Meizoso JP, Moore H, Moore EE. Fibrinolysis shutdown in COVID-19: clinical manifestations, molecular mechanisms, and therapeutic implications. J Am Coll Surg. 2021; 232: 995-1003. doi:10.1016/j.jamcollsurg.2021.02.019
- 5He S, Antovic A, Blombäck M. A simple and rapid laboratory method for determination of haemostasis potential in plasma: II. Modifications for use in routine laboratories and research work. Thromb Res. 2001; 103: 355-361. doi:10.1016/s0049-3848(01)00332-2
- 6Lim HY, Lui B, Tacey M, et al. Global coagulation assays in healthy controls: are there compensatory mechanisms within the coagulation system? J Thromb Thrombolysis. 2021; 52: 610-619. doi:10.1007/s11239-021-02400-y
- 7Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315: 762-774. doi:10.1001/jama.2016.0288
- 8Juneja GK, Castelo M, Yeh CH, et al. Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: a single-center prospective longitudinal study. J Thromb Haemost. 2021; 19: 1546-1557. doi:10.1111/jth.15327
- 9Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020; 18: 1324-1329. doi:10.1111/jth.14859
- 10Nougier C, Benoit R, Simon M, et al. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis. J Thromb Haemost. 2020; 18: 2215-2219. doi:10.1111/jth.15016
- 11Bouck EG, Denorme F, Holle LA, et al. COVID-19 and sepsis are associated with different abnormalities in plasma procoagulant and fibrinolytic activity. Arterioscler Thromb Vasc Biol. 2021; 41: 401-414. doi:10.1161/ATVBAHA.120.315338
- 12Medcalf RL, Keragala C, Myles PS. Fibrinolysis and COVID-19: a plasmin paradox. J Thromb Haemost. 2020; 18: 2118-2122. doi:10.1111/jth.14960
Citing Literature
